Bullish Case: ELAN at $22.43 shows call volume 50% above puts and 70% more bullish than bearish risk across tenors. Helium's density concentrates mass at $22–23 (peak 0.148) with meaningful upside weight to $27–28, and the market prices deeper tails than Helium does. Mean-reverting behavior plus the Purdue One Health research partnership and Credelio/paraherbicide pipeline momentum favor a drift back toward $24–26.

Bearish Case: Price is down 13.6% in ninety days from $25.95, backwardation persists, and the term structure's near-expiry wings (10/16 puts 58–72 IV at strikes 21–22) price unresolved event risk. Historical return surface carries real mass at -15% to -30%, and Seresto/litigation-type headlines have repeatedly broken mean reversion before. A break below $21 opens $18–19.

Potential Outcomes:

• 38%: Range $21.50–$24.50 into Jan expiry; falsified by a sustained daily close outside the band.
• 25%: Recovery to $24.50–$27 on Credelio momentum or guidance reinforcement; watch persistent 24–27 call bid and Jan call volume (16 contracts at 27C).
• 20%: Dip to $19.50–$21.50 on safety/legal headline; confirmed by rising 19–21 put IV.
• 10%: Below $19.50 on severe ruling/recall; extreme short-dated put IV (>250%) stays elevated.
• 7%: Above $28 on deal/strategic catalyst.

October 14, 2026